HEAD-TO-HEAD COMPARISON
Mounjaro vs ZepboundTirzepatide vs Tirzepatide
Verdict: Both contain the same active molecule (tirzepatide). Choose Mounjaro or Zepbound based on FDA-approved indication: Mounjaro is type 2 diabetes, Zepbound is chronic weight management. Mounjaro reaches a higher maintenance dose (15 mg/week).
Side-by-side comparison
| Mounjaro | Zepbound | |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| Manufacturer | Eli Lilly | Eli Lilly |
| FDA approval | 2022 | 2023 |
| Indication | Type 2 diabetes glycemic control | Chronic weight management for adults with BMI 30+, or 27+ with at least one weight-related comorbidity |
| Starting dose | Step 1 of 6 | Step 1 of 6 |
| Maintenance target | 15 mg/week | 15 mg/week |
| Titration length | ~21 weeks | ~21 weeks |
| Mean weight loss | ~15 to 20% mean (off-label / secondary endpoint) | ~20.9% mean at 72 weeks (SURMOUNT-1) |
| HbA1c reduction | 2.0 to 2.5 pp (SURPASS) | ~2.2 pp (off-label in T2D) |
| Cost (US list) | ~$1,000 / mo US list | ~$1,060 / mo US list |
| Insurance | T2D indication usually covered | Patchy for obesity indication |
Who should pick which
- Pick Mounjaro if the primary clinical goal is glycemic control in Type 2 diabetes; the FDA indication aligns and insurance coverage is more reliable.
- Pick Zepbound if the primary goal is weight management with an obesity-indicated label. Higher maintenance dose and stronger trial weight-loss data.
- Consider Mounjaro (tirzepatide) if mean weight loss in published trials is the deciding factor. Dual GIP + GLP-1 mechanism produces the largest effect size in head-to-head data.
Switching between the two
Because Mounjaro and Zepbound share the same active molecule, transitioning between them is straightforward: align the new product's dose to your existing maintenance level, or step into it at the closest available pen strength. No washout is typically needed.
Open Tirzepatide Dose Calculator → Compare full titration schedules side by sideFrequently asked
Is Mounjaro better than Zepbound?
Both contain the same active molecule (tirzepatide). Choose Mounjaro or Zepbound based on FDA-approved indication: Mounjaro is type 2 diabetes, Zepbound is chronic weight management. Mounjaro reaches a higher maintenance dose (15 mg/week).
Can I switch from Mounjaro to Zepbound?
Because Mounjaro and Zepbound share the same active molecule, transitioning between them is straightforward: align the new product's dose to your existing maintenance level, or step into it at the closest available pen strength. No washout is typically needed.
Does Mounjaro produce more weight loss than Zepbound?
Mounjaro: ~15 to 20% mean (off-label / secondary endpoint). Zepbound: ~20.9% mean at 72 weeks (SURMOUNT-1). Direct comparisons depend on dose, duration, and population studied; check the linked trial citations on each brand page for full context.
Why is Mounjaro priced differently from Zepbound?
Mounjaro costs ~$1,000 / mo US list; Zepbound costs ~$1,060 / mo US list. Differences reflect manufacturer pricing strategy, FDA indication (obesity-labeled brands often face patchier insurance coverage than diabetes-labeled brands), and whether the product is a finished drug or a pharmacy compound.
Which is better for Type 2 diabetes, Mounjaro or Zepbound?
Mounjaro is FDA-approved for Type 2 diabetes; Zepbound is not. For T2D-specific use, the labeled product is the appropriate clinical choice and is more likely to be covered by insurance.
Related
For research informational use only. Not medical advice. Mounjaro is a registered trademark of its manufacturer. Consult a qualified healthcare provider for clinical decisions.